|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.5 TWD | -2.20% |
|
-1.11% | -9.46% |
| Apr. 11 | DV Biomed Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | DV Biomed Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
DV Biomed Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 923.44 million compared to TWD 887.4 million a year ago. Net income was TWD 148.02 million compared to TWD 136.37 million a year ago.
Basic earnings per share from continuing operations was TWD 2.4602 compared to TWD 2.2544 a year ago. Diluted earnings per share from continuing operations was TWD 2.4602 compared to TWD 2.2544 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.46% | 81.56M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
DV BIOMED CO., LTD. 
